Integrated DNA Technologies (IDT) will describe efforts to prevent the misuse of synthetic genomics, and presenting recent developments in RNAi research, at both Analytica and the RNAi World Congress
At Analytica 2008 in Munich, Damon Terrill, senior VP international legal and regulatory affairs for IDT, will present on the cooperative efforts of government and industry to counter the potential misuse of synthetic genomics for harmful purposes.
IDT is at the forefront of work by companies to develop improved gene sequence screening methods and more effective protocols for reporting and responding to possible security and safety risks.
IDT says its leadership in the USA prompted the European Industry Association on Synthetic Biology (IASB) to invite it to discuss with Analytica attendees from around the world the benefits of a truly international approach.
At the end of April, the emphasis shifts to exciting new areas in basic scientific research with Mark Behlke, IDT's senior vice president of molecular genetics and biophysics and chief scientific officer, presenting on the 'Use of Dicer-substrate siRNAs in animal research' and 'Evolution of miRNAs in the marsupial Monodelphis domestica'.
New research carried out by Behlke's group reports on a number of interesting findings in RNAi research in several different model systems, including studies done in rats, mice and opossums.
